About Carigent Therapeutics
Carigent Therapeutics is a company based in United States founded in 2007. Carigent Therapeutics offers products and services including Proprietary Platform and Therapeutic Agents.
- Headquarter United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Carigent Technologies
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$204.34 K (USD), Grant
Sep 15, 2016
-
Investors
HHS
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Carigent Therapeutics
Carigent Therapeutics offers a comprehensive portfolio of products and services, including Proprietary Platform and Therapeutic Agents.
A platform is utilized for the development of therapeutic agents, including controlled release and targeting features.
Agents are developed for various applications, incorporating surface ligands and multiple components from FDA-approved materials.
Funding Insights of Carigent Therapeutics
Investors in Carigent Therapeutics
Carigent Therapeutics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A government-backed foundation providing seed-stage investments to support small businesses.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Carigent Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Carigent Therapeutics
Investment portfolio details for Carigent Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Carigent Therapeutics
Detailed financials for Carigent Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Carigent Therapeutics Comparisons
Peer comparison for Carigent Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Carigent Therapeutics
Detailed competitors of Carigent Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Carigent Therapeutics
Complete news archive for Carigent Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Carigent Therapeutics
Carigent Therapeutics was founded in 2007.
Carigent Therapeutics is headquartered in United States.
Carigent Therapeutics was founded in 2007 and is based in the United States. Operations focus on the biotechnology sector, where next-generation therapeutic agents are created using a proprietary controlled-release platform. This technology supports controlled release of agents, surface ligand attachment, targeted delivery to specific sites, and integration of multiple agents into a single FDA-approved vehicle. Versatility is provided for developing various therapeutics.
Carigent Therapeutics offers Proprietary Platform and Therapeutic Agents.
Carigent Therapeutics has 2 investors. Key investors include HHS, and National Science Foundation.